Methods of treating aquaporin-mediated conditions
US9949991B2 · kind B2 · utility
10Cited by
16References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 6, 2014 |
| Grant date | Apr 24, 2018 |
| Priority date | — |
| Expiry date | Nov 6, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/09
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of selective aquaporin inhibitors, e.g., of aquaporin-4 or aquaporin-2, e.g., certain phenylbenzamide compounds, for the prophylaxis, treatment and control of aquaporin-mediated conditions, e.g., glioblastoma and ovarian hyperstimulation syndrome. The invention provides, inter alia, methods of treating or controlling a disease condition mediated by an aquaporin, e.g., diseases or conditions of water imbalance and other diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.